• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGilead

Gilead

Page 3 of 4
Iris Network Student
HealthThe First FDA-Approved Gene Therapy Can Cure a Type of Blindness—But May Cost $1 Million
By Sy MukherjeeDecember 19, 2017
Research Not Hysteria
HealthPHOTOS: The Incredible Advances We’ve Made in the War Against HIV on World AIDS Day
By Sy MukherjeeDecember 1, 2017
Iris Network Student
HealthGene Therapy Is Revolutionary Science That Can Cure Blindness. Is It Worth $1 Million a Pop?
By Sy MukherjeeNovember 16, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthThe FDA Just Approved a Second Revolutionary Gene Therapy. A Third Is Probably on the Way
By Sy MukherjeeOctober 19, 2017
Gilead Takes AIDS Drug-Cocktail Approach To Fighting Cancer
HealthGilead’s Deal to Buy Kite Pharma Is a Game-Changer
By Sy MukherjeeAugust 28, 2017
Hepatitis C drug can cure, if patients can get it
HealthThe FDA Just Approved the First Drug That Can Treat All Hepatitis C Strains in Just 8 Weeks
By Sy MukherjeeAugust 3, 2017
HealthGilead Just Paid $125 Million to Nab a Big Market Advantage
By Sy MukherjeeFebruary 21, 2017
HealthThese 3 Ugly Patent Battles Could Rock Biopharma’s 2017
By Sy MukherjeeJanuary 7, 2017
World AIDS Day Is Marked Around The World
HealthWhy GSK’s Experimental HIV Drug Could Be a Safer Bet—And a Headache for Gilead
By Sy MukherjeeDecember 20, 2016
Hepatitis C drug can cure, if patients can get it
HealthMerck Won a Mammoth $2.5 Billion from Gilead After Its Hepatitis C Drug Patent Suit
By ReutersDecember 15, 2016
Wells Fargo CEO John Stumpf Testifies To The House Financial Services Committee
FinanceWells Fargo’s John Stumpf Is the Latest Victim of ‘CEO of the Year’ Curse
By Jen WiecznerOctober 14, 2016
HealthWhy the Fight Against AIDS Still Matters, in One Chart
By Matthew HeimerAugust 23, 2016
HealthWhistleblower Claims Celgene Colluded With Charities to Drive Profits
By Sy MukherjeeAugust 1, 2016
Inside of a Gilead Sciences Lab
HealthThe First-Ever Drug to Treat All Major Hep C Strains Just Got Approved
By Sy MukherjeeJune 29, 2016
New Hepatitis C wonder drug is costly
HealthWhy Gilead May Not Have to Pay Merck $200 Million After All
By Sy MukherjeeJune 7, 2016
1
  • 1
  • 2
  • 3
  • 4
4
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO commander warnsAn image of a popular article
By Jason MaFebruary 28, 2026
Success
Walmart exec says U.S. workforces needs to take inspiration from China where ‘5 year-olds are learning DeepSeek’An image of a popular article
By Preston ForeFebruary 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.